We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+6.52%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$15.2B
AUM Growth
-$714M
Cap. Flow
-$1.36B
Cap. Flow %
-8.94%
Top 10 Hldgs %
15.97%
Holding
2,218
New
180
Increased
888
Reduced
1,035
Closed
85
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPLA icon
1651
LPL Financial
LPLA
$28.6B
$580K ﹤0.01%
4,080
-1,476
-27% -$188K
OMF icon
1652
OneMain Financial
OMF
$7.47B
$580K ﹤0.01%
10,797
+557
+5% +$28.8K
CELH icon
1653
Celsius Holdings
CELH
$7.03B
$579K ﹤0.01%
+36,150
New +$679K
TTGT icon
1654
TechTarget
TTGT
$278M
$579K ﹤0.01%
8,337
-7,840
-48% -$610K
NSP icon
1655
Insperity
NSP
$2.01B
$578K ﹤0.01%
6,902
-1,141
-14% -$97K
WIRE
1656
DELISTED
Encore Wire Corp
WIRE
$578K ﹤0.01%
8,609
+1,527
+22% +$98.8K
CROX icon
1657
Crocs
CROX
$6.55B
$577K ﹤0.01%
7,175
-5,790
-45% -$441K
CORT icon
1658
Corcept Therapeutics
CORT
$12B
$575K ﹤0.01%
24,170
-21,167
-47% -$565K
SHAK icon
1659
Shake Shack
SHAK
$2.87B
$570K ﹤0.01%
5,053
+405
+9% +$46.3K
VIPS icon
1660
Vipshop
VIPS
$7.53B
$568K ﹤0.01%
19,031
-27,362
-59% -$944K
SPH icon
1661
Suburban Propane Partners
SPH
$1.18B
$567K ﹤0.01%
38,254
-7,409
-16% -$112K
GNMK
1662
DELISTED
GenMark Diagnostics, Inc
GNMK
$564K ﹤0.01%
+23,601
New +$439K
ACLS icon
1663
Axcelis
ACLS
$4.33B
$562K ﹤0.01%
13,674
+47
+0.3% +$1.75K
IDCC icon
1664
InterDigital
IDCC
$8.89B
$561K ﹤0.01%
+8,849
New +$578K
ATI icon
1665
ATI
ATI
$31B
$560K ﹤0.01%
26,614
-2,796
-10% -$54.7K
JMIA
1666
Jumia Technologies
JMIA
$767M
$559K ﹤0.01%
+15,765
New +$755K
BAND
1667
Bandwidth Inc
BAND
$1.61B
$557K ﹤0.01%
+4,395
New +$681K
SNEX icon
1668
StoneX
SNEX
$7.94B
$557K ﹤0.01%
43,122
-40,511
-48% -$488K
BHE icon
1669
Benchmark Electronics
BHE
$2.96B
$552K ﹤0.01%
+17,860
New +$512K
CSAN icon
1670
Cosan
CSAN
$2.84B
$551K ﹤0.01%
+34,128
New +$552K
TRIL
1671
DELISTED
Trillium Therapeutics Inc.
TRIL
$550K ﹤0.01%
51,197
+24,415
+91% +$302K
PBH icon
1672
Prestige Consumer Healthcare
PBH
$2.6B
$548K ﹤0.01%
12,425
-7,518
-38% -$316K
FPRX
1673
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$548K ﹤0.01%
+14,558
New +$363K
FTI icon
1674
TechnipFMC
FTI
$27.3B
$547K ﹤0.01%
70,797
-114,018
-62% -$932K
ENBL
1675
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$546K ﹤0.01%
84,144
+24,638
+41% +$153K

Similar funds

Guggenheim Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Guggenheim Capital held 2,218 positions worth $15.2B, down 4.5% from $15.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital withdrew a net $1.36B in Q1 2021, closing 85 positions and reducing 1,035 holdings. Its most notable exit was Gores Holdings VI, Inc. Unit, an estimated $42.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant worth $153M.

  • Guggenheim Capital's largest Q1 2021 buy was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant: 15,276,972 shares worth $153M.
  • Guggenheim Capital added most to Pioneer Natural Resource Co. in Q1 2021, an estimated $19.4M increase.
  • Guggenheim Capital's biggest Q1 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.08B.
  • Guggenheim Capital fully exited Gores Holdings VI, Inc. Unit in Q1 2021, selling an estimated $42.4M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $15.2B portfolio in Q1 2021.
  • Guggenheim Capital opened 180 new positions and closed 85 in Q1 2021.
  • Guggenheim Capital's portfolio value fell 4.5% quarter-over-quarter to $15.2B.

Based on Guggenheim Capital's 13F filing for Q1 2021, filed 13 May 2021.